Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroids for tuberculous pleurisy.

M E Engel1, P T Matchaba, J Volmink

  • 1Faculty of Health Sciences, University of Cape Town, Department of Medicine, J47 Old Main Building, Groote Schuur Hospital, Observatory, South Africa, 7925. mark.engel@mrc.ac.za

The Cochrane Database of Systematic Reviews
|October 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of diabetic cardiomyopathy in low- and middle-income countries: a systematic review protocol.

Systematic reviews·2026
Same author

Erratum for Barth et al., "Molecular Epidemiology of Noninvasive and Invasive Group A Streptococcal Infections in Cape Town".

mSphere·2019
Same author

Molecular Epidemiology of Noninvasive and Invasive Group A Streptococcal Infections in Cape Town.

mSphere·2019
Same author

Burden of depressive symptoms and non-alcohol substance abuse; and their association with alcohol use and partner violence: a cross-sectional study in four sub-Saharan Africa countries.

Global mental health (Cambridge, England)·2018
Same author

Participation in research improves overall patient management: insights from the Global Rheumatic Heart Disease registry (REMEDY).

Cardiovascular journal of Africa·2018
Same author

When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework.

BMJ open·2017

Corticosteroids may reduce pleural fluid and thickening in tuberculous pleurisy but lack evidence for mortality benefits. Further research is needed, especially regarding adverse effects in HIV-positive individuals.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Clinical Medicine

Background:

  • Tuberculous pleurisy treatment often involves antituberculous therapy.
  • Adjunctive corticosteroids have shown inconsistent benefits and potential risks, particularly in HIV-positive patients.

Purpose of the Study:

  • To evaluate the efficacy and safety of adding corticosteroids to standard antituberculous drug regimens for tuberculous pleural effusion.

Main Methods:

  • Systematic review and meta-analysis of randomized and quasi-randomized controlled trials.
  • Searched multiple databases including Cochrane, MEDLINE, and EMBASE up to May 2007.
  • Data extraction and analysis using relative risks and weighted mean differences with 95% confidence intervals.

Main Results:

Related Experiment Videos

  • Corticosteroids reduced residual pleural fluid at four weeks and pleural thickening.
  • No significant effects were observed on mortality, respiratory function, or pleural adhesions.
  • Increased treatment discontinuation due to adverse events was noted, with a potential increased risk of Kaposi sarcoma in HIV-positive individuals.

Conclusions:

  • Insufficient evidence exists to recommend adjunctive corticosteroids for tuberculous pleurisy.
  • Further high-powered randomized controlled trials are necessary to assess effects on morbidity and mortality.
  • The impact of corticosteroids on HIV-related complications requires specific investigation.